Data presented here revealed sertindole as an inhibitor of STAT3 activation but also confirmed STAT3 blockage as an essential mechanism responsible for sertindole-induced apoptosis in bladder cancer cells (Figure 3). Here, STAT3 is linked to urinary bladder carcinoma.